about
Laboratory use of hepcidin in renal transplant recipientsAssociation of prohepcidin and hepcidin-25 with erythropoietin response and ferritin in hemodialysis patients.Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: a randomized controlled trial.Mammalian target of rapamycin (mTOR) inhibitors: potential uses and a review of haematological adverse effects.A novel immunological assay for hepcidin quantification in human serumUrinary hepcidin-25 and risk of acute kidney injury following cardiopulmonary bypassSerum prohepcidin levels are potential prognostic markers in patients with multiple myelomaUnderstanding and exploiting hepcidin as an indicator of anemia due to chronic kidney disease.Serum prohepcidin levels are lower in patients with atrophic gastritis.Hepcidin in anemia and inflammation in chronic kidney disease.The Impact of Sex and Age on Serum Prohepcidin Concentration in Healthy Adults.Hepcidin--a potential novel biomarker for iron status in chronic kidney disease.Inflammation and its impact on anaemia in chronic kidney disease: from haemoglobin variability to hyporesponsiveness.Hepcidin: Homeostasis and Diseases Related to Iron Metabolism.Synthetic hepcidin causes rapid dose-dependent hypoferremia and is concentrated in ferroportin-containing organs.Hepcidin-25 concentrations are markedly increased in patients with chronic kidney disease and are inversely correlated with estimated glomerular filtration rates.Serum pro-hepcidin as an indicator of iron status in dialysis patients.SRM-MS Method Development for Hepcidin-25 Peptide.
P2860
Q26765316-D97D8A40-0509-4A7D-BEED-8BE02D4E553CQ33303027-4B8A3926-EAE8-4469-AE9B-1BD820FCC9CBQ33356816-2AC2404A-4ADA-4FF8-B4E6-FA1F3B845EDEQ33393707-E48F242F-21E3-4A84-BE63-29FBEC0FF31CQ33411750-8157A217-8891-4059-84EB-EAAA8B767C9FQ34008322-CF01F89D-773D-46E6-B6D6-84DC41AA1281Q36409102-5727A264-6032-428D-8D72-6478CFF24A63Q36471843-F7B1CBED-9934-48DD-8FD8-D64DB488724EQ36702756-35A15860-5484-4035-B379-6EF6A2D937D9Q36704221-A2872C2C-D6A2-45E5-8470-3C98264CE89CQ37155248-DBEBD856-FF9C-4E4A-B30C-0DD99ED4E414Q37211057-0BAAB3AB-DAEE-4A4F-9E38-07D338F3EA0BQ37492328-B6114F75-CDDC-43E8-95BA-DE67AE701F4BQ39313303-3EB2AF9E-1476-4788-806B-B9361812E4F6Q42146910-71F1338A-B33A-41A9-9935-FB1B7A32EC25Q45790281-66409819-E8A8-4544-92B9-2024C5DE853FQ46575102-42FAE323-89E6-4E69-AC5C-5CBF2D661AEEQ55667446-BCB90043-DB37-406A-9F1D-BF379ACE9F93
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Prohepcidin accumulates in renal insufficiency.
@en
Prohepcidin accumulates in renal insufficiency.
@nl
type
label
Prohepcidin accumulates in renal insufficiency.
@en
Prohepcidin accumulates in renal insufficiency.
@nl
prefLabel
Prohepcidin accumulates in renal insufficiency.
@en
Prohepcidin accumulates in renal insufficiency.
@nl
P2093
P2860
P356
P1476
Prohepcidin accumulates in renal insufficiency
@en
P2093
Birgitte Wuyts
Johan R Boelaert
Joris R Delanghe
Youri E C Taes
P2860
P304
P356
10.1515/CCLM.2004.069
P577
2004-04-01T00:00:00Z